NPI: 1730187899 · SPOKANE, WA 99204 · 261QM1300X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,173 | $793K |
| 2019 | 17,013 | $934K |
| 2020 | 17,162 | $921K |
| 2021 | 20,279 | $1.04M |
| 2022 | 23,047 | $1.49M |
| 2023 | 22,555 | $1.43M |
| 2024 | 23,194 | $1.40M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J0178 | Aflibercept injection | 2,501 | 2,353 | $2.84M |
| 92004 | 13,085 | 12,433 | $730K | |
| 92014 | 16,552 | 15,946 | $664K | |
| 99213 | 9,989 | 9,622 | $590K | |
| 99214 | 6,428 | 6,229 | $573K | |
| 99204 | 4,471 | 4,350 | $546K | |
| 67028 | 12,516 | 11,752 | $433K | |
| J2778 | Ranibizumab injection | 388 | 380 | $370K |
| 92015 | 43,838 | 38,936 | $323K | |
| 99203 | 2,727 | 2,679 | $253K | |
| 92134 | 19,506 | 18,059 | $233K | |
| J2777 | Inj, faricimab-svoa, 0.1mg | 91 | 88 | $145K |
| 92012 | 2,401 | 2,191 | $76K | |
| 92060 | 2,666 | 2,511 | $69K | |
| 00142 | 771 | 748 | $49K | |
| J9035 | Bevacizumab injection | 585 | 553 | $40K |
| 92340 | 2,717 | 2,715 | $26K | |
| 92083 | 760 | 725 | $13K | |
| 66984 | 66 | 61 | $6K | |
| 67311 | 12 | 12 | $5K | |
| 92250 | 392 | 364 | $4K | |
| 92133 | 296 | 278 | $3K | |
| 92136 | 554 | 393 | $3K | |
| 92002 | 27 | 25 | $797.43 | |
| 83516 | 32 | 25 | $560.51 | |
| J7999 | Compounded drug, noc | 12 | 12 | $390.64 |
| 83861 | 15 | 13 | $287.28 | |
| V2020 | Vision svcs frames purchases | 12 | 12 | $228.00 |
| 99211 | 13 | 13 | $205.13 |